½ÃÀ庸°í¼­
»óǰÄÚµå
1666942

DNA Æ÷·»½Ä ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)

DNA Forensics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 132 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ DNA Æ÷·»½Ä ½ÃÀåÀº 2024³â¿¡´Â 35¾ï ´Þ·¯°¡ µÇ¾ú°í, 2025³âºÎÅÍ 2034³â¿¡ °ÉÃÄ CAGR 5.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

DNA Æ÷·»½ÄÀº ¹üÁË ¼ö»ç, ºÎ¸ð¿Í ÀÚ½Ä °¨Á¤, ÀçÇØ ÇÇÇØÀÚÀÇ ½Å¿ø È®ÀÎ µîÀÇ ¸ñÀûÀ¸·Î À¯Àü ¹°ÁúÀ» »ç¿ëÇÏ¿© ¹ýÀûÀÎ Àå¸é¿¡¼­ µµ¿òÀÌ µË´Ï´Ù.

DNA Forensics Market-IMG1

½ÃÀåÀº ŰƮ, ºÐ¼®±â, ½ÃÄö¼­, ¼ÒÇÁÆ®¿þ¾î, ¼Ò¸ðǰÀ» Æ÷ÇÔÇÑ ¼Ö·ç¼Ç À¯Çü¿¡ µû¶ó ºÐ·ùµË´Ï´Ù. ¼Ò¸ðǰ ºÎ¹®Àº ½ÃÀåÀ» ¼±µµÇßÀ¸¸ç 2024³â¿¡´Â 37.7%ÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. À̰ÍÀº Â÷¼¼´ë ½ÃÄö¼­ ¹× ±âŸ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ DNA ºÐ¼®ÀÇ ¼Óµµ¿Í Á¤È®¼ºÀÌ Çâ»óµÈ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °³¼±À¸·Î ÀÎÇØ ÀÌ·¯ÇÑ °øÁ¤¿¡ ÇʼöÀûÀÎ ¼Ò¸ðǰ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 35¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 62¾ï ´Þ·¯
CAGR 5.4%

DNA Æ÷·»½Ä ½ÃÀåÀº ±â¹ýº°·Î ¸ð¼¼°ü Àü±â¿µµ¿(CE), Â÷¼¼´ë ½ÃÄö½Ì(NGS), ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ÁõÆø, ±âŸ ±â¹ýÀ¸·Î ±¸ºÐµË´Ï´Ù. ¸ð¼¼°ü Àü±â¿µµ¿(CE)ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2024³â¿¡´Â 12¾ï ´Þ·¯ÀÇ ¼öÀÍÀ» ¿Ã·È½À´Ï´Ù. CE´Â DNA ´ÜÆíÀ» °íÇØ»óµµ·Î ºÐ¸®ÇÏ°í ¹ýÀÇÇÐ ¿ëµµ¿¡ ÇʼöÀûÀÎ Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇÔÀ¸·Î½á Áö¿øµË´Ï´Ù. ¿­È­µÈ DNA »ùÇðú È¥ÇÕ DNA »ùÇÃÀ» ó¸®ÇÒ ¼ö ÀÖ´Â °ÍÀÌ Å« ÀÌÁ¡À̸ç, ¹ýÀÇÇÐ ¿¬±¸¼Ò¿¡ ÇʼöÀûÀÎ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹ÌÇØ°á »ç°ÇÀÇ ÇØ°á°ú °Ë»çÀÇ Á¤Ã¼¿¡ ´ëÇÑ ´ëó¸¦ ¸ñÀûÀ¸·Î ÇÑ ¹ý ÁýÇà ±â°ü¿¡ ÀÇÇÑ DNA Æ÷·»½Ä ±â¼ú¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ´Â ½Å¼ÓÇÏ°í ½Å·Ú¼º ³ôÀº DNA ºÐ¼®À» ½ÇÇöÇÏ´Â CE¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ DNA Æ÷·»½Ä ½ÃÀåÀº ´ëÆøÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖÀ¸¸ç, 2034³â¿¡´Â 24¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Á¤ºÎ´Â ¹üÁË ¼ö»ç °­È­¸¦ Áö¿øÇϱâ À§ÇØ °úÇÐ ¼ö»ç ±â¼ú ¾÷±×·¹À̵å¿Í ¿¬±¸¼Ò ½Ã¼³ È®Àå¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀÚ·Î ÃÖ÷´Ü DNA¹ýÀÇÇбâ¼úÀÇ Ã¤¿ëÀÌ ¹Ì±¹¿¡¼­ °¡¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¹ÌÇØ°á »ç°ÇÀÇ ÇØ°á°ú ¹ýÀÇÇבּ¸¼ÒÀÇ Ã¼·ù½Ã°£ ÃÖ¼ÒÈ­¿¡ ÁßÁ¡À» µÐ ³ë·ÂÀÌ DNA°¨Áö ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¹ý ÁýÇà ±â°üÀº ¹ÌÇØ°á »ç°ÇÀ» ÀçÁ¶»çÇϱâ À§ÇÑ µµ±¸·Î DNA Áõ°Å¸¦ Á¡Á¡ ´õ ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¾÷°è »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¹ýÀÇÇÐ ÇÁ·Î±×·¥¿¡ ´ëÇÑ Á¤ºÎÀÇ ´ëó¿Í ÀÚ±Ý
      • Ä£ÀÚ È®ÀÎ ¹× °¡Á· °ü°è Å×½ºÆ®ÀÇ ±â¼ú ¹ßÀü
      • ¹üÁË È°µ¿ Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© ¹× °úÁ¦
      • ±â±âÀÇ ³ôÀº ºñ¿ë
      • ½ÅÈï ±¹°¡¿¡¼­ÀÇ ¼÷·Ã Àü¹®°¡ ºÎÁ·
  • ¹ýÀÇÇÐ ¿¬±¸¼ÒÀÇ ¼ö : ÁÖ¿ä ±¹°¡º°
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
    • ij³ª´Ù
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߰衤¿¹Ãø : ¼Ö·ç¼Çº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ŰƮ
  • ºÐ¼®±â ¹× ½ÃÄö¼­
  • ¼ÒÇÁÆ®¿þ¾î
    • LIMS
    • ±âŸ ¼ÒÇÁÆ®¿þ¾î À¯Çü
  • ¼Ò¸ðǰ

Á¦6Àå ½ÃÀå Ã߰衤¿¹Ãø : ¹æ¹ýº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¸ð¼¼°ü Àü±â¿µµ¿(CE)
  • Â÷¼¼´ë ½ÃÄö½Ì(NGS)
  • PCR ÁõÆø
  • ±âŸ ¹æ¹ý

Á¦7Àå ½ÃÀå Ã߰衤¿¹Ãø : ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¹üÁËÀÚ °Ë»ç
  • Ä£ÀÚ È®ÀÎ ¹× °¡Á· °Ë»ç

Á¦8Àå ½ÃÀå Ã߰衤¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Danaher Corporation
  • GORDIZ
  • Illumina
  • Laboratory Corporation of America Holdings
  • LabVantage Solution
  • LabWare
  • Promega Corporation
  • Qiagen
  • Thermo Fisher Scientific
  • VERISIS
KTH 25.04.07

The Global DNA Forensics Market was valued at USD 3.5 billion in 2024 and is projected to grow at a 5.4% CAGR between 2025 and 2034. DNA forensics helps in legal settings by using genetic material for identification purposes, such as criminal investigations, paternity testing, and disaster victim identification.

DNA Forensics Market - IMG1

The market is categorized by solution types, including kits, analyzers, sequencers, software, and consumables. The consumables segment leads the market, contributing the largest share of 37.7% in 2024. This is largely due to the advancements in Next-Generation Sequencing and other technologies, which have enhanced the speed and precision of DNA analysis. These improvements have led to an increased demand for consumables essential for these processes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.5 Billion
Forecast Value$6.2 Billion
CAGR5.4%

Method-wise, the DNA forensics market is divided into capillary electrophoresis (CE), next-generation sequencing (NGS), polymerase chain reaction (PCR) amplification, and other methods. Capillary electrophoresis (CE) holds the largest share, generating a revenue of USD 1.2 billion in 2024. CE is favored for its high-resolution separation of DNA fragments, offering precise results critical for forensic applications. Its ability to handle degraded or mixed DNA samples is a major advantage, making it indispensable in forensic laboratories. The continued investment in DNA forensics technology by law enforcement agencies, aimed at solving cold cases and addressing testing backlogs, has further driven the demand for CE, as it delivers rapid and reliable DNA analysis.

U.S. DNA forensics market is poised for significant growth, with projections reaching USD 2.4 billion by 2034. The U.S. government has been investing heavily in upgrading forensic technology and expanding laboratory facilities to support enhanced criminal investigations. Such investments are expected to accelerate the adoption of cutting-edge DNA forensic technologies across the country. Additionally, initiatives focused on resolving cold cases and minimizing backlogs in forensic labs are intensifying the demand for DNA forensics solutions. Law enforcement agencies increasingly prioritize DNA evidence as a tool to revisit unsolved cases, further contributing to market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 Synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Government initiatives and funds for forensic programs
      • 3.2.1.2 Technological advancements in paternity and familial testing
      • 3.2.1.3 Increasing criminal activities
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of equipment
      • 3.2.2.2 Dearth of skilled professional in developing countries
  • 3.3 Number of forensic labs, by prominent countries
  • 3.4 Growth potential analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Canada
    • 3.5.3 Germany
    • 3.5.4 UK
    • 3.5.5 France
    • 3.5.6 Italy
    • 3.5.7 Spain
    • 3.5.8 China
    • 3.5.9 Japan
    • 3.5.10 India
    • 3.5.11 Brazil
    • 3.5.12 Mexico
  • 3.6 Porter’s analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Solution, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Kits
  • 5.3 Analyzers and sequencers
  • 5.4 Software
    • 5.4.1 LIMS
    • 5.4.2 Other software types
  • 5.5 Consumables

Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capillary electrophoresis (CE)
  • 6.3 Next generation sequencing (NGS)
  • 6.4 PCR amplification
  • 6.5 Other methods

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Criminal testing
  • 7.3 Paternity and familial testing

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Bio-Rad Laboratories
  • 9.3 Danaher Corporation
  • 9.4 GORDIZ
  • 9.5 Illumina
  • 9.6 Laboratory Corporation of America Holdings
  • 9.7 LabVantage Solution
  • 9.8 LabWare
  • 9.9 Promega Corporation
  • 9.10 Qiagen
  • 9.11 Thermo Fisher Scientific
  • 9.12 VERISIS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦